Literature DB >> 10760053

Regulation of the epithelial Na+ channel by aldosterone: open questions and emerging answers.

H Garty1.   

Abstract

Aldosterone is the principal adrenal steroid controlling Na+ retention in amphibians and mammalians. It acts primarily by increasing the apical Na+ permeability through activation of the epithelial Na+ channel (ENaC). The cellular events mediating the hormonal action are mostly unknown. Early studies have provided evidence that the hormone functions to activate or translocate pre-existing channels by a yet undefined mechanism. In addition, enhanced de novo channel synthesis appears to take place as well. The molecular cloning of the three ENaC subunits has provided new powerful tools for testing and confirming this hypothesis, as well as for characterizing mechanisms by which ENaC is regulated. Another important development is the recent identification of several cDNAs corresponding to aldosterone-induced and suppressed mRNAs. The study of these genes and their putative interactions with ENaC is likely to provide important clues to the mechanisms by which aldosterone controls the apical Na+ permeability of tight epithelia. This article reviews recent developments in the field that may lead to the elucidation of the mechanisms by which the hormone controls Na+ transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760053     DOI: 10.1046/j.1523-1755.2000.00961.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Molecular physiology of urinary concentration defect in elderly population.

Authors:  B K Kishore; C M Kran; M Reif; A G Menon
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

Authors:  Jo El J Schultz; Sandra A Witt; Betty J Glascock; Michelle L Nieman; Peter J Reiser; Stacey L Nix; Thomas R Kimball; Thomas Doetschman
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  8-(4-chlorophenylthio)-guanosine-3',5'-cyclic monophosphate-Na stimulates human alveolar fluid clearance by releasing external Na+ self-inhibition of epithelial Na+ channels.

Authors:  Dong-Yun Han; Hong-Guang Nie; Xue-Feng Su; Xue-Mei Shi; Deepa Bhattarai; Meimi Zhao; Run-Zhen Zhao; Katlin Landers; Hua Tang; Lin Zhang; Hong-Long Ji
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

4.  Aldosterone stimulates surface expression of NHE3 in renal proximal brush borders.

Authors:  Alexander W Krug; Friderun Papavassiliou; Ulrich Hopfer; Karl J Ullrich; Michael Gekle
Journal:  Pflugers Arch       Date:  2003-04-09       Impact factor: 3.657

5.  Endogenous protease activation of ENaC: effect of serine protease inhibition on ENaC single channel properties.

Authors:  Adedotun Adebamiro; Yi Cheng; John P Johnson; Robert J Bridges
Journal:  J Gen Physiol       Date:  2005-10       Impact factor: 4.086

6.  Cpt-cAMP activates human epithelial sodium channels via relieving self-inhibition.

Authors:  Raul Molina; Dong-Yun Han; Xue-Feng Su; Run-Zhen Zhao; Meimi Zhao; Gretta M Sharp; Yongchang Chang; Hong-Long Ji
Journal:  Biochim Biophys Acta       Date:  2011-03-17

7.  Sub-chronic testosterone treatment increases the levels of epithelial sodium channel (ENaC)-α, β and γ in the kidney of orchidectomized adult male Sprague-Dawley rats.

Authors:  Su Yi Loh; Nelli Giribabu; Naguib Salleh
Journal:  PeerJ       Date:  2016-06-30       Impact factor: 2.984

8.  Two adjacent phosphorylation sites in the C-terminus of the channel's α-subunit have opposing effects on epithelial sodium channel (ENaC) activity.

Authors:  Alexei Diakov; Viatcheslav Nesterov; Anke Dahlmann; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2022-05-08       Impact factor: 4.458

9.  Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells.

Authors:  Katherine Pegg; Jie Zhang; Carol Pollock; Sonia Saad
Journal:  PPAR Res       Date:  2013-02-24       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.